Reducing bureaucracy in clinical trials: now is the time!

Reducing bureaucracy in clinical trials now is the time 1

Excessive administrative demands lead to rising costs and complexity, stagnation of clinical research in Europe, fewer academic clinical trials and limited access to innovative treatments.

Read more